1095 related articles for article (PubMed ID: 14968144)
1. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment of myocardial infarction in Canada 1999-2002.
Jackevicius CA; Alter D; Cox J; Daly P; Goodman S; Filate W; Newman A; Tu JV;
Can J Cardiol; 2005 Feb; 21(2):145-52. PubMed ID: 15729413
[TBL] [Abstract][Full Text] [Related]
4. Regional variation in the management of acute myocardial infarction in the province of Quebec.
Rodrigues EJ; Simpson E; Richard H; Pilote L
Can J Cardiol; 2002 Oct; 18(10):1067-76. PubMed ID: 12420042
[TBL] [Abstract][Full Text] [Related]
5. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
Haddad H; Searles G; Gillis A
Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
[TBL] [Abstract][Full Text] [Related]
6. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
8. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
[TBL] [Abstract][Full Text] [Related]
9. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
11. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
Rasmussen S; Abildstrom SZ; Rasmussen JN; Gislason GH; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Madsen M
Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858
[TBL] [Abstract][Full Text] [Related]
12. Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project.
Gregor RD; Bata IR; Brownell B; Wolf HK
Can J Cardiol; 2000 May; 16(5):596-603. PubMed ID: 10833539
[TBL] [Abstract][Full Text] [Related]
13. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
14. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group.
Can J Cardiol; 1992 Apr; 8(3):253-8. PubMed ID: 1576559
[TBL] [Abstract][Full Text] [Related]
16. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
17. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
[TBL] [Abstract][Full Text] [Related]
18. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.
Pilote L; Lavoie F; Ho V; Eisenberg MJ
CMAJ; 2000 Jul; 163(1):31-6. PubMed ID: 10920727
[TBL] [Abstract][Full Text] [Related]
19. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
Howlett JG; Johnstone DE; Sketris I; O'Reilly M; Horne GS; Cox JL;
Can J Cardiol; 2003 Mar; 19(4):439-44. PubMed ID: 12704493
[TBL] [Abstract][Full Text] [Related]
20. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
